We’re accepting new feeds for electronic laboratory reporting (ELR) from hospitals. ELR provides advantages to hospitals other than meaningful use attestation, including improved efficiency through reduced manual entry for laboratory technicians and infection control professionals, and increased timeliness and completeness of reporting, which improves health outcomes and reduces time required to follow up and complete case reports.
Laboratories wishing to onboard for ELR must register their intent to attest should complete the Meaningful Use Registration Form(opens in new window). Or, if labs are wishing to onboard for ELR but not attest for meaningful use, they should declare this intent via email to our ELR coordinator: CDPHE_ELR@state.co.us.
The onboarding laboratories will review the vocabulary and messaging standards and reporting requirements. They’ll generate and validate test messages using a standard tool, submitting the results to us.
Once your agency is ready to generate messages with the required standards, a test message will be sent using one of the secure methods. We\’ll validate this HL7 message. Completion of Step 3 meets meaningful use Stage 1 attestation requirements.
If the laboratory is ready to submit ongoing results, but we\’re not prepared to perform the validation, the laboratory may be placed on a waiting list for ongoing submission and validation. Facilities placed in the queue can attest for meaningful use Stage 2, if that’s their goal.
Once your HL7 message has been validated and a secure method of transfer has been successfully tested, ongoing production level data will be transferred from your system on at least a daily basis (weekdays only). These messages will be evaluated for vocabulary standards. The reports received will be matched against disease reports received from your facility from traditional methods.